About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Neuropsychiatry
›
top-articles
Department of Neuropsychiatry
343
(top 1%)
papers
8.2K
(top 1%)
citations
45
(top 1%)
h
-index
75
(top 1%)
g
-index
376
all documents
9.1K
doc citations
1.8K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial
Lancet, The
2018
706
2
Optogenetic Activation of Dorsal Raphe Serotonin Neurons Enhances Patience for Future Rewards
Current Biology
2014
200
3
Optogenetic Manipulation of Activity and Temporally Controlled Cell-Specific Ablation Reveal a Role for MCH Neurons in Sleep/Wake Regulation
Journal of Neuroscience
2014
187
4
In Vivo Visualization of Subtle, Transient, and Local Activity of Astrocytes Using an Ultrasensitive Ca2+ Indicator
Cell Reports
2014
158
5
5-HT1A receptors on mature dentate gyrus granule cells are critical for the antidepressant response
Nature Neuroscience
2015
156
6
Optogenetic Countering of Glial Acidosis Suppresses Glial Glutamate Release and Ischemic Brain Damage
Neuron
2014
154
7
Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
Psychiatry Research
2012
148
8
Persistence and compliance to antidepressant treatment in patients with depression: A chart review
BMC Psychiatry
2009
147
9
Electroconvulsive Therapy Modulates Resting-State EEG Oscillatory Pattern and Phase Synchronization in Nodes of the Default Mode Network in Patients With Depressive Disorder
Frontiers in Human Neuroscience
2019
133
10
Superior fluid intelligence in children with Asperger’s disorder
Brain and Cognition
2008
123
11
Influence of Deteriorating Ability of Emotional Comprehension on Interpersonal Behavior in Alzheimer-Type Dementia
Brain and Cognition
2001
122
12
A self-reported instrument for prodromal symptoms of psychosis: Testing the clinical validity of the PRIME Screen—Revised (PS-R) in a Japanese population
Schizophrenia Research
2008
117
13
Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice
Behavioural Brain Research
2013
117
14
Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data
Schizophrenia Bulletin
2013
109
15
High-Speed and Scalable Whole-Brain Imaging in Rodents and Primates
Neuron
2017
108
16
Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
Schizophrenia Research
2012
100
17
Existence of functional β
1
‐ and β
2
‐adrenergic receptors on microglia
Journal of Neuroscience Research
2002
96
18
Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study
Biological Psychiatry
2019
94
19
Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia
International Journal of Neuropsychopharmacology
2004
90
20
Optogenetic activation of serotonergic neurons enhances anxiety-like behaviour in mice
International Journal of Neuropsychopharmacology
2014
87
21
Distinct Circuits Underlie the Effects of 5-HT1B Receptors on Aggression and Impulsivity
Neuron
2015
87
22
Serum interleukin-18 levels are elevated in schizophrenia
Psychiatry Research
2000
79
23
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Molecular Psychiatry
2015
78
24
Physiological effects of a habituation procedure for functional MRI in awake mice using a cryogenic radiofrequency probe
Journal of Neuroscience Methods
2016
78
25
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia
JAMA Psychiatry
2015
77
26
Adult Hippocampal Neurogenesis Modulates Fear Learning through Associative and Nonassociative Mechanisms
Journal of Neuroscience
2015
76
27
Preinspiratory calcium rise in putative pre‐Bötzinger complex astrocytes
Journal of Physiology
2012
67
28
Reduced sense of agency in chronic schizophrenia with predominant negative symptoms
Psychiatry Research
2013
65
29
Impact of changing the Japanese term for “schizophrenia” for reasons of stereotypical beliefs of schizophrenia in Japanese youth
Schizophrenia Research
2009
64
30
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
Psychiatry Research
2018
62
31
Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol
Schizophrenia Research
2002
60
32
Transcultural Study of Schizophrenic Delusions
Psychopathology
1998
58
33
The evolution of antipsychotic switch and polypharmacy in natural practice — A longitudinal perspective
Schizophrenia Research
2011
57
34
Dimensions of temperament as vulnerability factors in depression
Molecular Psychiatry
2002
55
35
Development of 2‐hour suicide intervention program among medical residents: First pilot trial
Psychiatry and Clinical Neurosciences
2010
55
36
Short- and long-term functional plasticity of white matter induced by oligodendrocyte depolarization in the hippocampus
Glia
2014
54
37
Reward probability and timing uncertainty alter the effect of dorsal raphe serotonin neurons on patience
Nature Communications
2018
54
38
Different roles of distinct serotonergic pathways in anxiety-like behavior, antidepressant-like, and anti-impulsive effects
Neuropharmacology
2020
53
39
Frontal and temporal cortical functional recovery after electroconvulsive therapy for depression: A longitudinal functional near-infrared spectroscopy study
Journal of Psychiatric Research
2017
52
40
Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data
Psychopharmacology
2017
52
41
Augmentation of atypical antipsychotics with valproic acid. An open‐label study for most difficult patients with schizophrenia
Human Psychopharmacology
2009
51
42
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study
Neuropsychopharmacology
2020
50
43
Comparison of Schizophrenic Delusions between Japan and Germany
Psychopathology
1993
49
44
Optogenetic Activation of CA1 Pyramidal Neurons at the Dorsal and Ventral Hippocampus Evokes Distinct Brain-Wide Responses Revealed by Mouse fMRI
PLoS ONE
2015
49
45
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment
Journal of Alzheimer's Disease
2015
49
46
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies
Progress in Neuro-Psychopharmacology and Biological Psychiatry
2018
49
47
High-dose antidepressants affect near-infrared spectroscopy signals: A retrospective study
NeuroImage: Clinical
2017
48
48
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial
Neuropharmacology
2020
48
49
Comprehension of Emotions: Comparison between Alzheimer Type and Vascular Type Dementias
Dementia and Geriatric Cognitive Disorders
2000
47
50
Subjective assessments of the quality of life, well‐being and self‐efficacy in patients with schizophrenia
Psychiatry and Clinical Neurosciences
2009
47
site/software ©
exaly
; All materials licenced under
CC by-SA
.